POSTN, on the other hand, a crucial factor for fibroblast activation, was found to be elevated in patients with both severe and moderate COVID-19 compared to controls, which has been shown by others as well to be associated with critical illness [33] and has been suggested as a potential therapeutic target in IPF [24]. This evidence concerns the gene POSTN and COVID-19.